China’s Biopharma Sector To Grow At 20 Percent - Study
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The Chinese biopharmaceutical sector continues to grow by 20 percent each year, according to a study published in August by BioPlan Associates and the Society for Industrial Microbiology